Egypt Edition 
MENA+ Edition 
UAE Edition 
Saudi Edition 
AI + Innovation (MENA) 
Infrastructure 
Rameda throws its hat in the ring for GSK’s Egypt business
Ladies and gentlemen, we have a good, old-fashioned bidding war: Rameda Pharma is the latest to show interest in GlaxoSmithKline's…
A bidding war for GSK’s Egyptian arm?
Acdima may have just touched off a bidding war for GlaxoSmithKline's Egypt business, according to a regulatory filing (pdf) yesterday,…
What the markets are doing on 1 February 2021
Saudi Arabia is trying to rebrand Riyadh as the new Dubai: The kingdom has already attracted 24 multinationals to set…
Mideast M&A activity picked up in 2H2020, Egypt is #2 for outbound transactions
The value of M&A activity in the Middle East nosedived 51% y-o-y to USD 58.7 bn in 2020 as M&A…
Landmark M&A in pharma, education
The week ends with news of two landmark acquisitions, one each in pharma and education. LSE-listed Hikma Pharma plans to…
Galina pushes on with EGP 600 mn stake sale, EGX debut
Galina attracts local, international investor interest in EGP 600 mn stake sale, plans to offer 10% in EGX debut: Agrifoods…
An acquisition here, a stake sale there …
Suez Cement has sold its 51% stake in Kuwait’s Hilal Cement for EGP 155.8 mn, the company said in a…
What the markets are doing on 25 January 2021
Investors might be pinning their hopes on the Fed to maintain the emerging-market rally, which showed signs of faltering late…
Something went wrong. Please refresh the page and/or try again.